Pluristem Therapeutics Inc (PSTI)

[zzaatt]

It [Pluristem] will not provide any updates on the status of patients treated under compassionate use.

It just occured to me, as a possibility of why the company is being so reticent with information on compassionate use.

I think it's fair to assume that various regulatory authorities are trying to prevent, some disreputable companies from boosting their pps by making irresponsible or misleading claims.

Pluristem, like other companies that depend on regulators for their survival, have to be sensitive to the delicate feelings of the bureaucrats. However, that will NOT prevent good news from traveling fast, doctors will share their experiences with other health care professionals. I expect that we will still get feedback from the clinic, even if not directly from the company.